Dl-Alpha-Tocopherol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14476 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | craniostenosis cataract | KG + DL |
| 2 | mature cataract | KG + DL |
| 3 | tetanic cataract | KG + DL |
| 4 | diabetes mellitus type 2 associated cataract | KG + DL |
| 5 | immature cataract | KG + DL |
| 6 | diabetic cataract | KG + DL |
| 7 | nuclear senile cataract | KG + DL |
| 8 | cortical cataract | KG + DL |
| 9 | senile cataract | KG + DL |
| 10 | antithrombin deficiency type 2 | KG + DL |
| 11 | heparin cofactor 2 deficiency | KG + DL |
| 12 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 13 | diabetic retinopathy | KG + DL |
| 14 | drug-induced osteoporosis | KG + DL |
| 15 | severe nonproliferative diabetic retinopathy | KG + DL |
| 16 | thrombophilia | KG + DL |
| 17 | urinary bladder neoplasm | KG + DL |
| 18 | bladder squamous papilloma | KG + DL |
| 19 | bladder leiomyoma | KG + DL |
| 20 | bladder urothelial papilloma | KG + DL |
| 21 | acne (disease) | KG + DL |
| 22 | urinary bladder carcinoma | KG + DL |
| 23 | urinary bladder cancer | KG + DL |
| 24 | non-invasive bladder urothelial carcinoma | KG + DL |
| 25 | infiltrating bladder urothelial carcinoma | KG + DL |
| 26 | bladder signet ring cell adenocarcinoma | KG + DL |
| 27 | bladder urachal urothelial carcinoma | KG + DL |
| 28 | bladder mixed adenocarcinoma | KG + DL |
| 29 | bladder colloid adenocarcinoma | KG + DL |
| 30 | bladder colonic type adenocarcinoma | KG + DL |
| 31 | bladder clear cell adenocarcinoma | KG + DL |
| 32 | bladder urachal adenocarcinoma | KG + DL |
| 33 | bladder dome cancer | KG + DL |
| 34 | urinary system neoplasm | KG + DL |
| 35 | urachus cancer | KG + DL |
| 36 | bladder neck cancer | KG + DL |
| 37 | non-papillary transitional cell carcinoma of the bladder | KG + DL |
| 38 | ureteric orifice cancer | KG + DL |
| 39 | bladder lateral wall cancer | KG + DL |
| 40 | urinary bladder anterior wall cancer | KG + DL |
| 41 | bladder sarcoma | KG + DL |
| 42 | palmoplantar keratoderma, nonepidermolytic, focal 1 | KG + DL |
| 43 | hemorrhagic disease of newborn | KG + DL |
| 44 | bladder carcinoma in situ | KG + DL |
| 45 | bladder benign neoplasm | KG + DL |
| 46 | urothelial papilloma | KG + DL |
| 47 | urinary bladder small cell neuroendocrine carcinoma | KG + DL |
| 48 | lung cancer | KG + DL |
| 49 | colonic neoplasm | KG + DL |
| 50 | villous adenoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.